New research shows that treatment timing is key when it comes to deciding between immunotherapy and chemoimmunotherapy for ...

USC researchers are exploring how electric fields, combined with immunotherapy and chemotherapy, could extend survival for ...

In what may signal the start of a new era in cancer therapy, South Korean researchers at KAIST (Korea Advanced Institute of ...

During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive ...

Median overall survival was 5 months longer in patients with small cell lung cancer (SCLC) who received tarlatamab instead of ...

New data support tailoring regional nodal irradiation in patients treated with neoadjuvant chemotherapy on the basis of their ...

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

A new state-of-the-art cancer center is opening its doors in Lackawanna County, bringing more care options to patients close ...

Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumors, according ...